Medpace Holdings, Inc. (MEDP)
NASDAQ · Healthcare · Medical - Diagnostics & Research
Profile
Medpace Holdings, Inc.
- Exchange
- NASDAQ
- Ticker
- MEDP
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Country
- US
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
Key facts
Medpace Holdings, Inc.: key facts
- Medpace Holdings, Inc. (NASDAQ: MEDP) is a Medical - Diagnostics & Research company in the Healthcare sector.
- In fiscal 2025, Medpace Holdings, Inc. reported revenue of $2.5B and net income of $451.1M.
- Revenue grew 22.0% a year over the last 4 fiscal years.
- Free cash flow was positive in 5 of the last 5 fiscal years.
- Net income was positive in 5 of the last 5 fiscal years.
- Over the last twelve months, revenue was $2.8B and net income was $517.8M.
MonkScore
Medpace Holdings, Inc.'s MonkScore
MonkScore
MonkScore range: 90–100
as of October 2026
Sector rank: 4 of 628 in Healthcare
How this score is madeDisclaimer
Pillar ranges
- Growth90–100
- Profitability90–100
- Quality80–90
- Market Conviction90–100
- Safety80–90
The MonkScore runs from 0 to 100. Each range is one of ten 10-point groups, from 0–10 to 90–100.
Each pillar's range uses the same ten groups. The exact score and the pillar scores are in the MonkStreet app.
Fundamentals
Figures from the statements
Medpace Holdings, Inc.'s annual figures and the last twelve months, in USD. Last report: 30 September 2026.
| Figure | Last 12 months | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Revenue | $2.8B | $2.5B | $2.1B | $1.9B | $1.5B | $1.1B |
| Gross profit | $827.2M | $760.6M | $656.3M | $524.5M | $432.4M | $328.2M |
| Operating income | $607.1M | $534.9M | $446.9M | $336.8M | $278.7M | $198.6M |
| Net income | $517.8M | $451.1M | $404.4M | $282.8M | $245.4M | $181.8M |
| Operating cash flow | $723.0M | $713.2M | $608.8M | $433.4M | $388.1M | $263.3M |
| Capital expenditure | -$55.4M | -$31.4M | -$36.5M | -$36.6M | -$36.9M | -$28.3M |
| Free cash flow | $667.6M | $681.9M | $572.3M | $396.7M | $351.2M | $235.1M |
| Total debt | $146.0M | $136.9M | $149.5M | $164.5M | $208.1M | $147.2M |
| Cash | $705.3M | $497.0M | $669.4M | $245.4M | $28.3M | $461.3M |
Revenue growth a year
- 1-year
- 20.0%
- 3-year
- 20.1%
- 4-year
- 22.0%
Compound growth between fiscal years.
Score my top stocks · 14-day free trial · card required · not charged during the trial · cancel in one click
MonkStreet provides research, not investment advice.
Page built on 31 October 2026.